View Older Stories View More Recent Stories
-
Apollo Medical Holdings To Present At The 2018 RBC Capital Markets Global Healthcare Conference
-
Big Oil takes stage for post-austerity beauty contest
-
Airbus halts some deliveries, tests after engine snag: sources
-
Inflation data for big economies may test nervy markets again
-
Immune Design to Present at Upcoming Investor Conferences
-
PTC Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
-
Immune Design to Present at Upcoming Investor Conferences
-
Expedia shares sink after disappointing 2018 forecast
-
SAGE Therapeutics (SAGE) Prices 3.5M Shares at $164
-
RBC Capital Upgrades Teva Pharma (TEVA) to Sector Perform
-
Cadence Bancorporation (CADE) Prices 8M Share Upsized Common Offering at $25/Sh
-
RBC Capital Upgrades Viacom (VIAB) to Sector Perform
-
RBC Capital Upgrades Domtar (UFS) to Outperform, Says to Buy The Dip
-
RBC Capital Upgrades Chevron (CVX) to Sector Perform Citing More Blaanced Risk/Reward
-
RBC Capital Upgrades BorgWarner (BWA) to Outperform
-
Cadence Bancorporation Announces Upsize and Pricing of Secondary Offering of Class A Common Stock by Cadence Bancorp, LLC
-
Senior Housing Properties Trust Prices $500 Million of 4.750% Senior Notes Due 2028
-
Orchid Island Capital Announces Fourth Quarter 2017 Results
-
RBC Capital Upgrades Twitter, Inc. (TWTR) to Sector Perform
-
Gilead Sciences to Present at the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, February 21
-
Thomas H. Lee Partners to Acquire Alfresco Software
-
Victory Capital (VCTR) IPO Opens Down 6%
-
RBC Capital Assumes Immunogen Inc. (IMGN) at Outperform
-
Alder BioPharmaceuticals® to Present at Two Upcoming February Investor Conferences
-
Akebia Therapeutics to Present at Upcoming February Investor Conferences
-
Alder BioPharmaceuticals® to Present at Two Upcoming February Investor Conferences
-
Canadian dollar to strengthen on further interest rate hikes: Reuters poll
-
Cardinal Health Reports Second-quarter Results for Fiscal Year 2018
-
Edge Therapeutics to Present at Upcoming Investor Conferences in February
-
Thomson Reuters beats profit forecast, misses on revenue
-
RBC Capital Starts Intra-Cellular Therapies (ITCI) at Outperform
-
Cactus Inc. (WHD) Prices 23M Share IPO AT $19/Sh
-
Victory Capital Holdings Inc. (VCTR) Prices 11.7M Share IPO at $13/Sh
-
RBC Capital Assumes Spark Therapeutics (ONCE) to Outperform
-
RBC Capital Starts Aurinia Pharmaceuticals (AUPH) at Outperform
-
Victory Capital Announces Pricing of Initial Public Offering
-
Cadence Bancorporation (CADE) Announces Proposed 7M Secondary Offering of Class A Common Stock by Cadence Bancorp, LLC
-
Cadence Bancorporation Announces Proposed Secondary Offering of Class A Common Stock by Cadence Bancorp, LLC
-
TransMontaigne Partners L.P. Announces Pricing of Public Offering of Senior Notes
-
Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2017
-
Depomed to Present at Healthcare Conferences in February
-
Johnson & Johnson to Participate in RBC Capital Markets 2018 Global Healthcare Conference
-
Intra-Cellular Therapies to Present at Upcoming Investor Conferences
-
BeyondSpring to Present at Upcoming Investor Conferences
-
Xencor to Present at Upcoming Investor Conferences
-
Snap shares surge after app redesign sparks user growth
-
Karyopharm to Participate in Upcoming Investor Conferences
-
AVEO Oncology to Present at Upcoming Conferences
-
Karyopharm to Participate in Upcoming Investor Conferences


